Next-Generation Sleep Disorder Treatment System

A wearable dental appliance with integrated sensors and AI-powered software predicts and prevents sleep apnea episodes, while a cloud-based platform enables remote monitoring and personalized treatment adjustments.

The original patent, 'Method and system for homogeneous dental appliance', addressed the limitations of traditional dental appliances for sleep apnea treatment. However, these appliances lacked real-time monitoring and personalized adjustments, leading to suboptimal treatment outcomes. The new inventive concept addresses this limitation by integrating sensors, AI-powered software, and cloud-based remote monitoring to provide more effective and personalized sleep disorder treatment.

The next-generation sleep disorder treatment system comprises a wearable dental appliance with integrated sensors that track a patient's sleep patterns, oral characteristics, and medical history. The appliance communicates with a cloud-based platform, which utilizes machine learning algorithms to analyze the data and provide personalized treatment recommendations. The system also includes a mobile app for tracking sleep quality and apnea events, and a cloud-based analytics platform for identifying trends and providing recommendations for improving sleep health. The dental appliance can be customized using machine learning algorithms to optimize airflow and comfort features, and can be manufactured using 3D printing or other advanced techniques.

The new inventive concept introduces a paradigm shift in sleep disorder treatment by integrating real-time monitoring, AI-powered software, and cloud-based remote monitoring. This enables personalized treatment adjustments, improved treatment outcomes, and enhanced patient engagement. The use of machine learning algorithms to customize the dental appliance and predict sleep apnea episodes is a novel and non-obvious advancement over the original patent.

Alternative embodiments of the inventive concept could include the use of different sensor technologies, such as MEMS sensors or EEG sensors, or the integration of additional features, such as snore detection or sleep stage tracking. The system could also be adapted for use with other sleep disorders, such as insomnia or restless leg syndrome.

The next-generation sleep disorder treatment system has significant commercial potential in the sleep health industry, which is projected to reach $17.4 billion by 2025. The system could be marketed to sleep clinics, hospitals, and dental offices, as well as directly to consumers through online platforms or retail partnerships.